Ajanta Pharma moves up on launching Omeprazole and Sodium Bicarbonate Capsules in US Market

18 Jul 2016 Evaluate

Ajanta Pharma is currently trading at Rs 1623.80, up by 25.70 points or 1.61% from its previous closing of Rs. 1598.10 on the BSE.

The scrip opened at Rs. 1604.80 and has touched a high and low of Rs. 1647.00 and Rs. 1593.90 respectively. So far 26919 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 1720.00 on 12-Aug-2015 and a 52 week low of Rs. 1103.00 on 18-Jan-2016.

Last one week high and low of the scrip stood at Rs. 1659.00 and Rs. 1591.40 respectively. The current market cap of the company is Rs. 14450.86 crore.

The promoters holding in the company stood at 73.78%, while Institutions and Non-Institutions held 12.06% and 14.16% respectively.

Ajanta Pharma has received the final approval from US Food and Drug Administration (US FDA) and launched Omeprazole and Sodium Bicarbonate Capsules in the US market through its wholly owned subsidiary Ajanta Pharma USA Inc. It is a bioequivalent prescription generic version of Zegerid and the company has launched the product in 2 strengths 20mg/1100mg & 40mg/1100mg capsules.

Omeprazole and Sodium Bicarbonate Capsules is part of an ever-growing portfolio of products that Ajanta has developed for the US market. In total, Ajanta has 26 Abbreviated New Drug Application (ANDA) of which it has final approvals for 11 ANDAs; tentative approvals for 1 ANDA; and 14 ANDAs are under review with US FDA.

Ajanta Pharma Share Price

2638.75 12.50 (0.48%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×